These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 5122447

  • 1. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
    Danielczyk W, Korten JJ.
    Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
    Buscaino GA, Campanella G, Zallone E.
    Minerva Med; 1971 Oct 31; 62(82):3974-8. PubMed ID: 5125057
    [No Abstract] [Full Text] [Related]

  • 5. [Current treatment of Parkinsonism with amantadine hydrochloride].
    Gerstenbrand F, Gründig E, Musiol A.
    Pol Tyg Lek; 1972 Jul 03; 27(23):878-9. PubMed ID: 5040531
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic association of amantadine and L-Dopa in parkinsonism].
    Signorelli CD, D'Andrea F, De Divitiis E, Cerillo A.
    Minerva Med; 1971 Oct 31; 62(82):4015-6. PubMed ID: 5125068
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H, Gurtner B.
    Schweiz Med Wochenschr; 1972 Apr 22; 102(16):583-6. PubMed ID: 5019377
    [No Abstract] [Full Text] [Related]

  • 8. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1971 Aug 22; 26(8):61-70. PubMed ID: 5096462
    [No Abstract] [Full Text] [Related]

  • 9. Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism.
    Puca FM, Bricolo A, Turella G.
    Electroencephalogr Clin Neurophysiol; 1973 Sep 22; 35(3):327-30. PubMed ID: 4126184
    [No Abstract] [Full Text] [Related]

  • 10. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
    De Divitiis E, D'Andrea F, Signorelli CD, Cerillo A.
    Minerva Med; 1971 Oct 31; 62(82):4007-8. PubMed ID: 5125065
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I, Bulandra R, Serbanesco A, Ninosu N.
    Rev Neurol (Paris); 1972 Aug 31; 127(2):305-8. PubMed ID: 4672049
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E, Fischer PA, Jacobi P.
    Med Klin; 1974 Mar 29; 69(13):541-5. PubMed ID: 4831456
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C, Martinelli P.
    Minerva Med; 1971 Oct 31; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract] [Full Text] [Related]

  • 14. The management of parkinsonism.
    N Z Med J; 1971 Jul 31; 74(470):36-7. PubMed ID: 5289750
    [No Abstract] [Full Text] [Related]

  • 15. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS, England AC.
    Trans Am Neurol Assoc; 1969 Jul 31; 94():85-90. PubMed ID: 4907453
    [No Abstract] [Full Text] [Related]

  • 16. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa].
    Ferraris M.
    Minerva Med; 1971 Oct 31; 62(82):3971-3. PubMed ID: 5125056
    [No Abstract] [Full Text] [Related]

  • 17. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM, Micalizzi V, Megna GF, Barbieri NF, Pigneri MT.
    Acta Neurol (Napoli); 1971 Oct 31; 26(6):707-30. PubMed ID: 4946491
    [No Abstract] [Full Text] [Related]

  • 18. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
    Giuffrè R, Gambacorta D.
    Minerva Med; 1971 Oct 31; 62(82):4009-12. PubMed ID: 5125066
    [No Abstract] [Full Text] [Related]

  • 19. [Amantadine therapy in parkinsonism].
    Pakkenberg H.
    Ugeskr Laeger; 1973 Jan 15; 135(3):135-6. PubMed ID: 4685048
    [No Abstract] [Full Text] [Related]

  • 20. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M, Jorgensen PB.
    Aust N Z J Med; 1972 Aug 15; 2(3):252-5. PubMed ID: 4564049
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.